References
- Campana LG, Clover AJ, Valpione S, Quaglino P, Gehl J, Kunte C, et al. Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review. Radiol Oncol 2016; 50: 1-13. doi: 10.1515/raon-2016-0006
- Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874-82. doi:10.1080/0284186X.2018.1454602
- Campana LG, Miklavčič D, Bertino G, Marconato R, Valpione S, Imarisio I, et al. Electrochemotherapy of superficial tumors - current status: basic principles, operating procedures, shared indications, and emerging applications. Semin Oncol 2019; 46: 173-91. doi: 10.1053/j.seminoncol.2019.04.002
- Edhemovic I, Brecelj E, Gasljevic G, Snoj M, Miklavcic D, Gadzijev E, et al. Intraoperative electrochemotherapy of colorectal liver metastases. J Surg Oncol 2014; 110: 320-7. doi: 10.1002/jso.23625
- Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, et al. Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. Eur J Surg Oncol 2018; 44: 651-7. doi: 10.1016/j.ejso.2018.01.090
- Edhemovic I, Brecelj E, Cemazar M, Boc N, Trotovsek B, Djokic M, et al. Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study. Eur J Surg Oncol 2020; Epub ahead of print. doi: 10.1016/j.ejso.2020.04.037
- Johnson BW, Wright GP. Regional therapies for the treatment of primary and metastatic hepatic tumors: a disease-based review of techniques and critical appraisal of current evidence. Am J Surg 2019; 217: 541-5. doi: 10.1016/j.amjsurg.2018.10.018
- Lyu C, Lopez-Ichikawa M, Rubinsky B, Chang TT. Normal and fibrotic liver parenchyma respond differently to irreversible electroporation. HPB 2019; 21: 1344-53. doi: 10.1016/j.hpb.2019.01.019
- Geboers B, Scheffer HJ, Graybill PM, Ruarus AH, Nieuwenhuizen S, Puijk RS, et al. High-voltage electrical pulses in oncology: Irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy. Radiology 2020; 295: 254-72. doi: 10.1148/radiol.2020192190
- Miklavčič D, Mali B, Kos B, Heller R, Serša G. Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online 2014; 13: 29. doi: 10.1186/1475-925X-13-29
- Brloznik M, Boc N, Sersa G, Zmuc J, Gasljevic G, Seliskar A, et al. Radiological findings of porcine liver after electrochemotherapy with bleomycin. Radiol Oncol 2019; 53: 415-26. doi: 10.2478/raon-2019-0049
- Zmuc J, Gasljevic G, Sersa G, Edhemovic I, Boc N, Seliskar A, et al. Large liver blood vessels and bile ducts are not damaged by electrochemotherapy with beomycin in pigs. Sci Rep 2019; 9: 3649. doi: 10.1038/s41598-019-40395-y.
- Gasljevic G, Edhemovic I, Cemazar M, Brecelj E, Gadzijev EM, Music MM, et al. Histopathological findings in colorectal liver metastases after electrochemotherapy. PLoS One 2017; 12: e0180709. doi: 10.1371/journal.pone.0180709.
- Probst U, Fuhrmann I, Beyer L, Wiggermann P. Electrochemotherapy as a new modality in interventional oncology: a review. Technol Cancer Res Treat 2018; 17: 1533033818785329. doi: 10.1177/1533033818785329
- Sutter O, Calvo J, N’kontchou G, Nault J-C, Ourabia R, Nahon P, et al. Safety and efficacy of irreversible electroporation for the treatment of hepatocellular carcinoma not amenable to thermal ablation techniques. Radiology 2017; 284: 877-86. doi: 10.1148/radiol.2017161413
- Kalra N, Gupta P, Gorsi U, Bhujade H, Chaluvashetty SB, Duseja A, et al. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience. Cardiovasc Intervent Radiol 2019; 42: 584-90. doi: 10.1007/s00270-019-02164-2
- Kalra N. Locoregional treatment for hepatocellular carcinoma: the best is yet to come. World J Radiol 2015; 7: 306-18. doi: 10.4329/wjr.v7.i10.306
- Gasbarrini A, Campos WK, Campanacci L, Boriani S. Electrochemotherapy to metastatic spinal melanoma: a novel treatment of spinal metastasis? Spine 2015; 40: E1340-6. doi: 10.1097/BRS.0000000000001125
- Cornelis FH, Ben Ammar M, Nouri-Neuville M, Matton L, Benderra MA, Gligorov J, et al. Percutaneous image-guided electrochemotherapy of spine metastases: initial experience. Cardiovasc Intervent Radiol 2019; 42: 18069. doi: 10.1007/s00270-019-02316-4
- Tarantino L, Busto G, Nasto A, Nasto RA, Tarantino P, Fristachi R, et al. Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a feasibility study. Eur J Surg Oncol 2018; 44: 1603-9. doi: 10.1016/j.ejso.2018.06.025
- Cindrič H, Kos B, Tedesco G, Cadossi M, Gasbarrini A, Miklavčič D. Electrochemotherapy of spinal metastases using transpedicular approach - a numerical feasibility study. Technol Cancer Res Treat 2018; 17: 1533034618770253. doi: 10.1177/1533034618770253
- Tarantino L, Busto G, Nasto A, Fristachi R, Cacace L, Talamo M, et al. Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: a feasibility study. World J Gastroenterol 2017; 23: 906-18. doi: 10.3748/wjg.v23.i5.906
- Cornelis FH, Cindrič H, Kos B, Fujimori M, Petre EN, Miklavčič D, et al. Peritumoral metallic implants reduce the efficacy of irreversible electroporation for the ablation of colorectal liver metastases. Cardiovasc Intervent Radiol 2020; 43: 84-93. doi: 10.1007/s00270-019-02300-y
- Mali B, Gorjup V, Edhemovic I, Brecelj E, Cemazar M, Sersa G, et al. Electrochemotherapy of colorectal liver metastases - an observational study of its effects on the electrocardiogram. Biomed Eng Online 2015; 14 Suppl 3: S5. doi: 10.1186/1475-925X-14-S3-S5
- Lu DS, Raman SS, Limanond P, Aziz D, Economou J, Busuttil R, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14: 1267-74. doi: 10.1097/01.rvi.0000092666.72261.6b
- Baker EH, Thompson K, McKillop IH, Cochran A, Kirks R, Vrochides D, et al. Operative microwave ablation for hepatocellular carcinoma: a single center retrospective review of 219 patients. J Gastrointest Oncol 2017; 8: 337-46. doi: 10.21037/jgo.2016.09.06
- Baker EH, Thompson K, McKillop IH, Cochran A, Kirks R, Vrochides D, et al. Operative microwave ablation for hepatocellular carcinoma: a single center retrospective review of 219 patients. J Gastrointest Oncol 2017; 8: 337-46. doi: 10.21037/jgo.2016.09.06
- Wang T, Lu XJ, Chi JC, Ding M, Zhang Y, Tang XY, et al. Microwave ablation of hepatocellular carcinoma as first-line treatment: long term outcomes and prognostic factors in 221 patients. Sci Rep 2016; 6: 32728. doi: 10.1038/srep32728
- Ding J, Jing X, Liu J, Wang Y, Wang F, Wang Y, et al. Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques. Clin Radiol 2013; 68: 608-15. doi: 10.1016/j.crad.2012.12.008
- Lucchina N, Tsetis D, Ierardi AM, Giorlando F, Macchi E, Kehagias E, et al. Current role of microwave ablation in the treatment of small hepatocellular carcinomas. Ann Gastroenterol 2016; 29: 460-5. doi: 10.20524/aog.2016.0066
- Ding J, Jing X, Liu J, Wang Y, Wang F, Wang Y, et al. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma. Eur J Radiol 2013; 82: 1379-84. doi: 10.1016/j.ejrad.2013.04.025
- Distelmaier M, Barabasch A, Heil P, Kraemer NA, Isfort P, Keil S, et al. Midterm safety and efficacy of irreversible electroporation of malignant liver tumors located close to major portal or hepatic veins. Radiology 2017; 285: 1023-31. doi: 10.1148/radiol.2017161561
- Pompili M, Francica G. Irreversible electroporation for hepatic tumors. J Ultrasound 2019; 22: 1-3. doi: 10.1007/s40477-019-00367-4
- Mafeld S, Wong JJ, Kibriya N, Stenberg B, Manas D, Bassett P, et al. Percutaneous irreversible electroporation (IRE) of hepatic malignancy: a bi-institutional analysis of safety and outcomes. Cardiovasc Intervent Radiol 2019; 42: 577-83. doi: 10.1007/s00270-018-2120-z
- Mali B, Jarm T, Corovic S, Paulin-Kosir MS, Cemazar M, Sersa G, et al. The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput 2008; 46: 745-57.
https://doi.org/10.1007/s11517-008-0346-7 - Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in “out of operation theatre” anaesthesia. Anesth Analg 2010; 110: 1305-9. doi: 10.1213/ANE.0b013e3181d27b30
- Mekid H, Tounekti O, Spatz A, Cemazar M, Kebir E, Mir LM. In vivo evolution of tumour cells after the generation of double-strand DNA breaks. Br J Cancer 2003; 88: 1763-71. doi: 10.1038/sj.bjc.6600959
- Markelc B, Sersa G, Cemazar M. Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PLoS One 2013; 8: e59557. doi: 10.1371/journal.pone.0059557
- Calvet CY, Famin D, André FM, Mir LM. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. Oncoimmunology 2014; 3: e28131. doi: 10.4161/onci.28131
- Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G et al. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother 2015; 64: 1315-27. doi: 10.1007/s00262-015-1724-2
- Heppt MV, Eigentler TK, Kähler KC, Herbst RA, Göppner D, Gambichler T, et al. Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis. Cancer Immunol Immunother 2016; 65: 951-9. doi: 10.1007/s00262-016-1856-z